Authors
Latest:
Race/Ethnicity, Personal Health Record Access, and Quality of CareQuality benefits were equal across racial/ethnic groups with equal personal health record (PHR) use, but nonwhite status and a preference for Spanish language predicted lower PHR registration.
Latest:
Out-of-Pocket Healthcare Expenditure Burdens Among Nonelderly Adults With HypertensionAmong nonelderly adults receiving hypertension treatment, 13.1% had high burdens, meaning that healthcare expenditures accounted for more than 20% of their income.
Latest:
Trends in Inpatient Hospital Prices, 2008 to 2010A comprehensive presentation of intensity-adjusted hospital price levels and growth rates, including national detail on more than 350 types of hospitalizations, and regional and local averages.
Latest:
Communication About Diabetes Risk Factors During Between-Visit EncountersIn an integrated delivery system among patients with diabetes, there was significantly less risk factor communication reported during between-visit encounters compared with in-person visits.
Latest:
Association of Co-pay Elimination With Medication Adherence and Total CostThis study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.
Latest:
Case Study: How Does an ACO Generate Savings Three Years in a Row?Increasing accountable care organization savings is dependent on maximizing quality scores and increasing the number of beneficiaries while maintaining a low per-capita spend through efficiencies of care.
Latest:
Economic and Clinical Impact of Routine Weekend Catheterization ServicesWeekend cardiac catheterization availability for inpatients reduced length of stay and maintained quality of care (no excess hazard for weekend cases), but costs were similar.
Latest:
Connecting Statewide Health Information Technology Strategy to Payment ReformWhen aggregated data regarding health outcomes are shared, a clearer picture emerges of provider performance baselines and improvements with which payment models can be developed.
Latest:
Characteristics of and Trends in the Late-stage Biopharmaceutical PipelineResearch on characteristics of the biopharmaceutical pipeline and on changes since 2003 includes a description of new features and recommendations for health policy decision makers.
Latest:
New Start Versus Continuing Users on Aripiprazole: Implications for PolicyNew starts on aripiprazole were less adherent than continuing users. Prescriptions for 90-day supplies should be reserved for patients who have established effectiveness and tolerance.
Latest:
It Is Time to Ask Patients What Outcomes Are Important to ThemPatients with abdominal or back pain identified 21 outcomes important to them, but the reported outcomes are quite different from the symptom and function outcomes studied by researchers.
Latest:
Measuring Financial Toxicity in Cancer PatientsWith the rising costs of cancer care, evidence-based tools can help physicians screen patients for financial toxicity.
Latest:
Effectiveness of Care Coordination and Health Counseling in Advancing IllnessThis prospective trial suggests that specialized care coordination and health counseling for patients coping with advanced stages of 4 life-limiting illnesses can be beneficial.
Latest:
Hypertension Treatment and Control Within an Independent Nurse Practitioner SettingThis cross-sectional retrospective study found comparable blood pressure control rates among patients with hypertension receiving primary care from a nurse practitioner versus a physician.
Latest:
Understanding Vaccination Rates and Attitudes Among Patients With Rheumatoid ArthritisPatients with rheumatoid arthritis self-report a moderate rate of any previous pneumococcal vaccination (54%) and a very low rate of herpes zoster vaccination (8%).
Latest:
US Payer Perspectives on Evidence for Formulary Decision MakingTo improve formulary design processes and support payers in providing more effective healthcare, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.
